Is LOBEF or JNJ a better dividend investment in 2026?

LOBEF currently yields 3861.00% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: LOBEF offers higher current income.

What is the dividend yield difference between LOBEF and JNJ?

LOBEF has a forward dividend yield of 3861.00% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3857.64 percentage points.

Home › Compare › LOBEF vs JNJ

LOBEF vs JNJ: Dividend Comparison 2026

LOBEF yields 3861.00% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LOBEF wins by $5102776617539.98M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LOBEF

● Live price

3861.00%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5102776617540.00M

Annual income

$4,855,397,881,919,778,000.00

Full LOBEF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — LOBEF vs JNJ

📍 LOBEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LOBEF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LOBEF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LOBEF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LOBEF

Annual income on $10K today (after 15% tax)

$328,185.33/yr

After 10yr DRIP, annual income (after tax)

$4,127,088,199,631,811,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, LOBEF beats the other by $4,127,088,199,631,810,600.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LOBEF + JNJ for your $10,000?

LOBEF: 50%JNJ: 50%

100% JNJ50/50100% LOBEF

Portfolio after 10yr

$2551388308770.01M

Annual income

$2,427,698,940,959,889,400.00/yr

Blended yield

95.15%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LOBEF

No analyst data

Altman Z

-9.3

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LOBEF buys

JNJ buys

No recent congressional trades found for LOBEF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLOBEFJNJ

Forward yield	3861.00% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$5102776617540.00M ✓	$20.0K
Annual income after 10y	$4,855,397,881,919,778,000.00 ✓	$827.78
Total dividends collected	$5085877075297.57M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: LOBEF vs JNJ ($10,000, DRIP)

Year	LOBEF Portfolio	LOBEF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$396,800	$386,100.39	$10,676	$355.77	+$386.1K → LOBEF
2	$14,742,780	$14,318,203.95	$11,407	$389.39	+$14.73M → LOBEF
3	$512,952,973	$497,178,198.17	$12,198	$426.53	+$512.94M → LOBEF
4	$16,715,748,598	$16,166,888,916.48	$13,056	$467.62	+$16715.74M → LOBEF
5	$510,255,139,456	$492,369,288,456.53	$13,987	$513.12	+$510255.13M → LOBEF
6	$14,592,492,784,652	$14,046,519,785,434.00	$14,998	$563.56	+$14592492.77M → LOBEF
7	$391,042,310,644,499	$375,428,343,364,921.60	$16,098	$619.52	+$391042310.63M → LOBEF
8	$9,820,789,713,309,148	$9,402,374,440,919,534.00	$17,295	$681.69	+$9820789713.29M → LOBEF
9	$231,195,080,018,900,830	$220,686,835,025,660,030.00	$18,599	$750.82	+$231195080018.88M → LOBEF
10	$5,102,776,617,540,002,000	$4,855,397,881,919,778,000.00	$20,022	$827.78	+$5102776617539.98M → LOBEF

LOBEF vs JNJ: Complete Analysis 2026

LOBEF — Stock

Lobe Sciences Ltd., a life sciences company, focuses on the research and development of psychedelic medicines. It develops psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder, as well as devices for the efficient application of medications. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

Full LOBEF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this LOBEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LOBEF vs SCHD LOBEF vs JEPI LOBEF vs O LOBEF vs KO LOBEF vs MAIN LOBEF vs ABBV LOBEF vs MRK LOBEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.